PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 62 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,260,000 | -89.6% | 1,145,740 | -69.3% | 0.00% | -92.9% |
| Q4 2018 | $12,097,000 | +36.0% | 3,733,664 | +1.2% | 0.01% | +75.0% |
| Q3 2018 | $8,893,000 | -13.0% | 3,690,138 | +0.7% | 0.01% | -20.0% |
| Q2 2018 | $10,222,000 | -40.6% | 3,663,710 | +1.2% | 0.01% | -41.2% |
| Q1 2018 | $17,204,000 | -7.2% | 3,621,854 | +14.0% | 0.02% | -5.6% |
| Q4 2017 | $18,530,000 | +326.1% | 3,178,432 | +53.5% | 0.02% | +350.0% |
| Q3 2017 | $4,349,000 | -55.2% | 2,070,936 | -0.2% | 0.00% | -60.0% |
| Q2 2017 | $9,713,000 | -36.5% | 2,075,439 | +6.2% | 0.01% | -37.5% |
| Q1 2017 | $15,287,000 | -41.6% | 1,954,864 | -8.5% | 0.02% | -44.8% |
| Q4 2016 | $26,184,000 | +36.6% | 2,135,708 | +73.7% | 0.03% | +38.1% |
| Q3 2016 | $19,166,000 | +89.2% | 1,229,362 | +47.2% | 0.02% | +90.9% |
| Q2 2016 | $10,130,000 | +25.7% | 835,103 | -0.1% | 0.01% | +37.5% |
| Q1 2016 | $8,060,000 | – | 836,122 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 722,890 | $911,000 | 0.53% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $4,410,000 | 0.44% |
| NEA Management Company, LLC | 5,556,778 | $7,002,000 | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 2,050,328 | $2,583,000 | 0.31% |
| HARBOURVEST PARTNERS LLC | 440,627 | $555,000 | 0.20% |
| VHCP Management II, LLC | 427,110 | $538,000 | 0.16% |
| Endurant Capital Management LP | 130,600 | $165,000 | 0.06% |
| ALGERT GLOBAL LLC | 64,300 | $81,000 | 0.05% |
| Bain Capital Public Equity Management, LLC | 231,418 | $292,000 | 0.03% |
| Kazazian Asset Management, LLC | 14,436 | $18,000 | 0.02% |